2018
DOI: 10.7150/ijms.25588
|View full text |Cite
|
Sign up to set email alerts
|

High Levels of Serum Adipocyte Fatty Acid-binding Protein Predict Cardiovascular Events in Coronary Artery Disease Patients

Abstract: Background: Adipocyte fatty acid-binding protein (A-FABP) is a cardiometabolic predictor of cardiovascular (CV) disease in humans. We evaluated the association between serum A-FABP levels and future CV events in patients with coronary artery disease (CAD).Methods: A total of 106 CAD patients were enrolled in this study between January and December 2012 and were followed-up until June 30, 2017. The primary endpoint was the incidence of major adverse CV events.Results: During a median follow-up period of 53 mont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…In women with gestational diabetes, serum A-FABP level is independently correlated with impaired glucose metabolism and increases the risk of progression to DM [20]. In addition, higher levels of circulating A-FABP are believed to be a biomarker for predicting unfavorable CV events in patients with coronary artery disease, end-stage renal disease, or critical illness [13,21,22]. In ApoE-deficient mice and in the human microvascular endothelium, previous work shows that A-FABP has an independent role in atherogenesis; additionally, enhanced expression of A-FABP was associated with reduced expression of eNOS and nitric oxide (NO) production [19,23].…”
Section: Discussionmentioning
confidence: 99%
“…In women with gestational diabetes, serum A-FABP level is independently correlated with impaired glucose metabolism and increases the risk of progression to DM [20]. In addition, higher levels of circulating A-FABP are believed to be a biomarker for predicting unfavorable CV events in patients with coronary artery disease, end-stage renal disease, or critical illness [13,21,22]. In ApoE-deficient mice and in the human microvascular endothelium, previous work shows that A-FABP has an independent role in atherogenesis; additionally, enhanced expression of A-FABP was associated with reduced expression of eNOS and nitric oxide (NO) production [19,23].…”
Section: Discussionmentioning
confidence: 99%
“…Height was measured to the nearest 0.5 cm, and body weight was measured to the nearest 0.5 kg in light clothing without shoes. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m 2 ) [ 7 11 ].…”
Section: Methodsmentioning
confidence: 99%
“…Serum albumin, blood urea nitrogen (BUN), Cre, fasting glucose, triglyceride (TG), total cholesterol (TCH), total calcium, phosphorus, and C-reactive protein (CRP) levels were measured with an autoanalyzer (Siemens Advia 1800, Siemens Healthcare GmbH, Henkestr, Germany) [ 7 10 ]. Serum A-FABP (SPI-BIO, Montigny le Bretonneux, France) and intact parathyroid hormone (iPTH) levels (Diagnostic Systems Laboratories, TX, USA) were measured with a commercial enzyme immunoassay and enzyme-linked immunosorbent assay (ELISA) [ 8 11 ].…”
Section: Methodsmentioning
confidence: 99%
“…were measured in light clothing without shoes (adjusted to nearest 0.5 kg and 0.5 cm, respectively), and body mass index (BMI) was calculated using Quetelet's formula (weight (kg)/ height (m 2 )) [16,20,21].…”
Section: Anthropometric Analysis Patient Weight and Heightmentioning
confidence: 99%
“…After an 8 h overnight fasting, approximately 5 mL blood was sampled from all participants and immediately centrifuged at 3000 g for 10 min. Serum blood urea nitrogen (BUN), creatinine, fasting glucose, TG, total cholesterol (TCH), HDL-C, LDL-C, and C-reactive protein (CRP) levels were determined using an autoanalyzer (COBAS Integra 800, Roche Diagnostics, Basel, Switzerland) [16,20,21]. Serum ANGPTL3 (R&D Systems, Inc., Minneapolis, MN) levels were quantified using the commercial enzyme-linked immunosorbent assay [16].…”
Section: Biochemical Investigationsmentioning
confidence: 99%